Homepage > Company > Media > Pharma News > 2020 > Britain's medical regulator says urgently reviewing AstraZeneca COVID-19 vaccine trial data

Britain's medical regulator says urgently reviewing AstraZeneca COVID-19 vaccine trial data

(Reuters) - Britain’s medical regulator said on Wednesday it is urgently reviewing information available to determine whether AstraZeneca can restart trials of its experimental coronavirus vaccine after an unexplained illness in a participant.

In an email, director of licensing at the Medicines and Healthcare products Regulatory Agency (MHRA) Siu Ping Lam said the regulator is working with the Oxford Vaccine Centre to review the safety data, in line with protocol for the trial.

“We are urgently reviewing all the information and actively engaging with the researchers to determine whether the trial should restart as quickly as possible,” he said.

Participant safety in any clinical trial is a top priority, he said. AstraZeneca is developing the potential vaccine with the University of Oxford.

SEPTEMBER 10, 2020

https://www.reuters.com/

Read also

FDA warns vs fake versions of popular medicines

MANILA, Philippines - counterfeit versions of some popular over-the-counter pain relievers and flu medicines are circulating in the market, the Food and Drug Administration (FDA) reported. ...

Japan's Eisai inks $2 B oncology deal with China-based startup Bliss Biopharma

Cognixion, a developer of non-invasive Brain-Computer Interface (BCI) and Augmented Reality (AR) technology, has announced that the US Food and Drug Administration (FDA) has granted its device Brea...

Cognixion receives FDA Breakthrough Device Designation for assisted communication device

EMA to review CTIS transparency rules

Public consultation seeks the best methods for balancing transparency with confidentiality in the EU Clinical Trials Information System, says the European Medicines Agency. ...